# Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults

> **NCT02021968** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 48 (actual)

## Conditions studied

- Dengue

## Interventions

- **BIOLOGICAL:** TetraVax-DV-TV003
- **BIOLOGICAL:** rDEN2∆30-7169
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02021968
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-03
- **Final completion:** 2015-12
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2015-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02021968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02021968, "Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02021968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*